Richter acquires Janssen transdermal contraceptive assets
Image by LaMography/Moni Lazar
Hungarian pharmaceutical company Gedeon Richter on Thursday said it agreed to acquire the Evra brand transdermal contraceptive patch assets for outside of the United States from Janssen Pharmaceutica NV, a unit of Johnson and Johnson, for USD 263.5 million, state news wire MTI reports.
Image by Lamography
Richter and Janssen also signed a transitional business license agreement and a series of other related agreements to run the business without interruption during the period required to transfer the marketing authorizations to Richter.
"Adding a patch to our existing contraceptive delivery methods such as oral contraceptives, emergency contraceptives and intrauterine device enables us to proudly offer the widest selection of family planning solutions to women," Richter chairman Erik Bogsch said.
Oral contraceptives are Richterʼs top-selling products.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.